Latest Cost Savings News

Gratifii Limited has posted a record $19.4 million in cash receipts for 4Q FY25, marking a 210% year-on-year increase and signaling strong momentum as it nears completion of its platform migration and expands its Member’s Mobile offering.

Capricorn Metals has announced a definitive plan to acquire Warriedar Resources, consolidating key Western Australian gold assets and enhancing production capacity. The all-scrip deal offers Warriedar shareholders a 29% premium and positions Capricorn for a combined 9.1 million ounce gold equivalent resource.

Epx Limited reports sustained operational improvement with four consecutive quarters of positive cash inflows and a 26% increase in customer receipts for the June 2025 quarter.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.

FleetPartners delivered a resilient 3Q25 performance with 5% growth in key metrics despite operational challenges from a major system upgrade. A recent $400 million asset-backed securitisation deal also improved funding costs, positioning the company for growth in underpenetrated markets.

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.

Noble Helium appoints Dennis Donald as Executive Chairman and secures a $200k loan to accelerate its North Rukwa helium project, backed by positive technical reviews.

PlaySide Studios has released its unaudited FY25 results, showing revenues just below guidance and an EBITDA loss within expectations amid restructuring. The company remains optimistic about revenue growth and cost savings in FY26, pending the launch of its new title.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.